HighTower Advisors LLC Boosts Stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

HighTower Advisors LLC boosted its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 32.5% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 10,311 shares of the company’s stock after purchasing an additional 2,529 shares during the period. HighTower Advisors LLC’s holdings in Establishment Labs were worth $446,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of ESTA. First Turn Management LLC purchased a new stake in shares of Establishment Labs during the 2nd quarter worth $16,812,000. Sofinnova Investments Inc. increased its stake in shares of Establishment Labs by 204.1% during the second quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company’s stock worth $19,505,000 after acquiring an additional 288,082 shares during the period. Divisadero Street Capital Management LP purchased a new position in shares of Establishment Labs during the 2nd quarter worth approximately $5,829,000. Millennium Management LLC raised its position in Establishment Labs by 49.8% in the second quarter. Millennium Management LLC now owns 273,605 shares of the company’s stock worth $12,433,000 after acquiring an additional 90,943 shares in the last quarter. Finally, Rice Hall James & Associates LLC lifted its holdings in Establishment Labs by 10.7% in the third quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company’s stock valued at $34,326,000 after acquiring an additional 76,959 shares during the period. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Trading Up 2.7 %

ESTA stock opened at $40.01 on Friday. Establishment Labs Holdings Inc. has a 52 week low of $23.38 and a 52 week high of $60.12. The company has a market cap of $1.12 billion, a price-to-earnings ratio of -15.51 and a beta of 1.16. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The business has a fifty day simple moving average of $43.69 and a 200-day simple moving average of $43.77.

Analyst Ratings Changes

ESTA has been the topic of a number of research reports. Citigroup upped their price target on Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. BTIG Research upped their target price on Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a report on Monday, October 14th. Finally, Stephens raised Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $60.60.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.